James Shaw

Clinical Professor/Consultant

Newcastle University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Shaw is a Clinical Professor and Consultant at Newcastle University in the UK. His research areas include the impacts of diabetes on pancreatic histology, glucose intolerance in cystic fibrosis, and hypoglycaemia awareness among diabetes patients. He has authored several recent articles examining insulin sensitivity, continuous glucose monitoring, and clinical trial protocols aimed at improving diabetes care and organ transplant outcomes.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (8)

Daniel McAuley

Professor - Concultant, Intensive Care Medicine

The Queen's University Belfast

UNITED KINGDOM

View details

Sarah Richardson

Associate Professor in Cellular Biomedicine

University of Exeter

UNITED KINGDOM

View details

Knut Stavem

NORWAY

View details

Daphne Kounali

University of Oxford

UNITED KINGDOM

View details

Michael Rickels

Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

View details

Neil Sheerin

Professor of Nephrology

Newcastle University

UNITED KINGDOM

View details

Helen Thomas

Head of Clinical Trial Statistics

NHS Blood and Transplant

UNITED KINGDOM

View details

Guy MacGowan

Hon Professor of Heart Failure

Newcastle University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Shaw

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Quantitative analysis of human adult pancreatic histology reveals separate fatty and fibrotic phenotypes in type 2 diabetes

Elucidating the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Intolerance in People With Cystic Fibrosis

EQ-5D-5L value set for Norway: a hybrid model using cTTO and DCE data

Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort

Evaluating Continuous Glucose Monitoring After Total Pancreatectomy With or Without Islet Autotransplantation A Scoping Systematic Review

Identification of a vimentin-expressing α-cell phenotype in CF and normal pancreas

SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients

Insulin sensitivity, disposition index and insulin clearance in cystic fibrosis: a cross-sectional study

A single‐site feasibility randomised controlled trial comparing ‘my hypo compass’ short pyscho‐educational intervention with standard care alone in individuals with type 1 diabetes and impaired awareness of hypoglycaemia

Collaborators (8)

Daniel McAuley

Sarah Richardson

Knut Stavem

Daphne Kounali

Michael Rickels

Neil Sheerin

Helen Thomas

Guy MacGowan

Make your next move.